Delivery Order SPE2DB22D1017-SPE2DB25FF6AR
Award Date
2/21/25
Potential Completion Date
2/24/25
Potential Value
$5.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,599.51 firm fixed price delivery order is for MESTINON 180 MG TIMESPAN UU 30S, a pharmaceutical product. The contract has an ultimate completion date of February 10, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,627.76 firm fixed-price delivery order is for the supply of 4566963200 units of MESTINON 180 MG TIMESPAN UU 30S, a pharmaceutical product. The contract has an ultimate completion date of January 17, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, with ID SPE2DB22D2214|SPE2DB25FS2ZD, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,661.88 firm fixed-price delivery order is for the supply of Mestinon 180 mg Timespan medication, with a period of performance through December 6, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $1,177.89 Firm Fixed Price Delivery Order is for the supply of MESTINON 180 MG TIMESPAN UU 30S, a prescription medication, with a period of performance through June 4, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. This...
The contract award (ID: SPE2DB24D1021|SPE2DB25FERKU) is for the delivery of Mestinon 180 mg Timespan pharmaceutical products to the Defense Logistics Agency (DLA). The $8,655.86 firm fixed-price contract with Amerisourcebergen Drug Corp, a major pharmaceutical distributor, has an ultimate completion date of October 17, 2024. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, which covers a wide range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,367.94 firm fixed-price delivery order is for the supply of MESTINON 180 MG TIMESPAN UU 30S, a medication used to treat myasthenia gravis. The contract has an ultimate completion date of May 17, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,395.46 firm fixed-price delivery order is for the supply of MESTINON 180 MG TIMESPAN UU 30S, a medication used to treat certain neurological conditions. The award has an ultimate completion date of January 28, 2025 and is not associated with a set-aside designation. AmerisourceBergen holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $23,645.38 firm fixed-price delivery order is for MESTINON 180 MG TIMESPAN UU 30S, a medication product. The contract has an ultimate completion date of November 26, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order valued at $5,475.69 with a completion date of January 9, 2025. The contract was awarded by the Defense Logistics Agency (DLA) and is for the supply of MESTINON 180 MG TIMESPAN UU 30S, a pharmaceutical product. Amerisourcebergen Drug Corp is the prime contractor and has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026. This IDC serves as a primary...
This contract award, issued by the Defense Logistics Agency (DLA), is for the delivery of Mestinon 180 mg Timespan medication to support federal healthcare programs. The $5,021.88 firm fixed-price contract has a completion date of February 19, 2025 and was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...